Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-16-053152)

Filing Details

Accession Number:: 0001127602-16-053152
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-23 17:56:16
Reporting Period:: 2016-05-23

Filing Date:: 2016-05-23
Accepted Time:: 2016-05-23 17:56:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1062822	Lexicon Pharmaceuticals Inc.	LXRX	Pharmaceutical Preparations (2834)	760474169

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1434095	F James Tessmer	8800 Technology Forest Place The Woodlands TX 77381	Vp, Finance & Accounting	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-23	6,000	$6.23	21,946	No	4	M	Direct
Common Stock	Disposition	2016-05-23	6,000	$13.00	15,946	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2016-05-23	6,000	$0.00	6,000	$6.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,899		2025-02-05	No	4	M	Direct

Footnotes

Effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Tessmer on May 16, 2016.
Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.